Close Menu

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – OpGen said today that it is working with the Beijing Genomics Institute to expand their use of OpGen's optical mapping technology for de novo sequence finishing in human, plant, and animal genomes.

The company said it has already used its Optical Mapping Technology with BGI to complete a study based on human genome data to successfully close gaps in existing sequence folds.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The New York Times looks at companies using genomic tools to try to quickly identify the cause of patients' infections.

The White House has asked for $2.5 billion in funding to address the COVID-19 outbreak, according to the Associated Press.

A resignation at the Marine Biological Laboratory highlights that institutions are unsure of how to handle researchers previously found to have violated codes of conduct, Nature News says.

In PNAS this week: immune responses that affect heart transplant rejection risk, gene variants associated with thiopurine toxicity, and more.